Terms: = Sarcomas AND PR, PGR, progesterone receptor AND Clinical Outcome
10 results:
1. Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Dall G; Vandenberg CJ; Nesic K; Ratnayake G; Zhu W; Vissers JHA; Bedő J; Penington J; Wakefield MJ; Kee D; Carmagnac A; Lim R; Shield-Artin K; Milesi B; Lobley A; Kyran EL; O'Grady E; Tram J; Zhou W; Nugawela D; Stewart KP; Caldwell R; Papadopoulos L; Ng AP; Dobrovic A; Fox SB; McNally O; Power JD; Meniawy T; Tan TH; Collins IM; Klein O; Barnett S; Olesen I; Hamilton A; Hofmann O; Grimmond S; Papenfuss AT; Scott CL; Barker HE
J Exp Clin Cancer Res; 2023 May; 42(1):112. PubMed ID: 37143137
[TBL] [Abstract] [Full Text] [Related]
2. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
Tseng WW; Barretta F; Conti L; Grignani G; Tolomeo F; Albertsmeier M; Angele MK; Rutkowski P; Skoczylas J; De Paoli A; Navarria F; Raut CP; Fairweather M; Farma JM; Nessim C; Goel N; Grignol VP; Ford SJ; Cardona K; Subhawong T; Tattersall HL; Lee RM; Hu JS; von Mehren M; Sanfilippo R; Gronchi A
Cancer; 2021 Mar; 127(5):729-738. PubMed ID: 33206381
[TBL] [Abstract] [Full Text] [Related]
3. clinical characteristics and outcomes of uterine tumors resembling ovarian sex-cord tumors (UTROSCT): a systematic review of literature.
Blake EA; Sheridan TB; Wang KL; Takiuchi T; Kodama M; Sawada K; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():163-70. PubMed ID: 25150955
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
5. Expression of hormonal receptors in osteosarcomas of the jaw bones: clinico-pathological analysis of 21 cases.
Domínguez-Malagón HR; González-Conde E; Cano-Valdez AM; Luna-Ortiz K; Mosqueda-Taylor A
Med Oral Patol Oral Cir Bucal; 2014 Jan; 19(1):e44-8. PubMed ID: 24121902
[TBL] [Abstract] [Full Text] [Related]
6. The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Kasper B; Schmitt T; Wuchter P; Dimitrakopoulou-Strauss A; Ho AD; Egerer G
Mar Drugs; 2009 Jul; 7(3):331-40. PubMed ID: 19841717
[TBL] [Abstract] [Full Text] [Related]
7. [Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Kasper B; Schmitt T; Wuchter P; Ho AD; Egerer G
Dtsch Med Wochenschr; 2009 Sep; 134(39):1922-6. PubMed ID: 19760551
[TBL] [Abstract] [Full Text] [Related]
8. Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Simoni A; Taddei A; Taddei GL
J Chemother; 2003 Dec; 15(6):596-602. PubMed ID: 14998087
[TBL] [Abstract] [Full Text] [Related]
9. Low-grade endometrial stromal sarcoma: hormonal aspects.
Chu MC; Mor G; Lim C; Zheng W; Parkash V; Schwartz PE
Gynecol Oncol; 2003 Jul; 90(1):170-6. PubMed ID: 12821359
[TBL] [Abstract] [Full Text] [Related]
10. The hormonal receptor status of uterine carcinosarcomas (mixed müllerian tumours): an immunohistochemical study.
Ansink AC; Cross PA; Scorer P; de Barros Lopes A; Monaghan JM
J Clin Pathol; 1997 Apr; 50(4):328-31. PubMed ID: 9215151
[TBL] [Abstract] [Full Text] [Related]
